SAR405838 effectively stabilizes p53 and activates the p53 pathway, resulting in abrogated cellular proliferation, cell-cycle arrest, and apoptosis in liposarcoma, lymphoma and leukemia with an intact MDM2-p53 axis [30, 37, 38]. This evidence concerns the gene MDM2 and leukemia.